Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Cuts Target Price to $20
AVITA Medical Analyst Ratings
Piper Sandler Reiterates Neutral on AVITA Medical, Raises Price Target to $12
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
Avita Medical: Strong Buy Rating Backed by Record Sales and Promising Growth Prospects
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
AVITA Medical Analyst Ratings
Lake Street Issues a Buy Rating on Avita Medical (RCEL)
BTIG Remains a Hold on Avita Medical (RCEL)
Avita Medical Maintains Buy Rating Amid Strong Quarterly Performance and Positive Growth Outlook
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $40
Avita Medical (RCEL) Gets a Buy From Lake Street
BTIG Keeps Their Hold Rating on Avita Medical (RCEL)
Lake Street Sticks to Their Buy Rating for Avita Medical (RCEL)
Buy Rating Affirmed: Avita Medical's Strategic Wins Promise Growth and Market Penetration
AVITA Downgraded by Piper Sandler Over Sales Outlook
AVITA Medical Analyst Ratings
Piper Sandler Reaffirms Their Hold Rating on Avita Medical (RCEL)
Steady Performance and Promising Outlook: A Buy Rating for Avita Medical